These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 19026356)

  • 21. Anemia: What can we learn from a secondary analysis of CHOIR?
    Hörl WH
    Nat Rev Nephrol; 2010 May; 6(5):251-2. PubMed ID: 20424625
    [No Abstract]   [Full Text] [Related]  

  • 22. Epoetin: for better or for worse?
    Lancet Oncol; 2004 Jan; 5(1):1. PubMed ID: 14700601
    [No Abstract]   [Full Text] [Related]  

  • 23. Effectiveness of a pharmacist-implemented anemia management protocol in an outpatient hemodialysis unit.
    To LL; Stoner CP; Stolley SN; Buenviaje JD; Ziegler TW
    Am J Health Syst Pharm; 2001 Nov; 58(21):2061-5. PubMed ID: 11715828
    [No Abstract]   [Full Text] [Related]  

  • 24. The Italian gynecological consensus statement on the use of epoetin alfa in the management of anemia.
    Pecorelli S;
    Semin Oncol; 2002 Jun; 29(3 Suppl 8):13-5. PubMed ID: 12082648
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of cancer-related anemia: epoetin alfa and quality of life.
    Soignet S
    Semin Hematol; 2000 Oct; 37(4 Suppl 6):9-13. PubMed ID: 11068950
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Case history. 1: the use of epoetin alfa in delayed anaemia.
    Mertelsmann R
    Ann Oncol; 1997; 8 Suppl 3():S11-2. PubMed ID: 9341960
    [No Abstract]   [Full Text] [Related]  

  • 27. Greater epoetin alfa responsiveness is associated with improved survival in hemodialysis patients.
    Kilpatrick RD; Critchlow CW; Fishbane S; Besarab A; Stehman-Breen C; Krishnan M; Bradbury BD
    Clin J Am Soc Nephrol; 2008 Jul; 3(4):1077-83. PubMed ID: 18417744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Darbepoetin alfa, a new therapy for the management of anemia of chronic kidney disease.
    Hudson JQ; Sameri RM
    Pharmacotherapy; 2002 Sep; 22(9 Pt 2):141S-149S. PubMed ID: 12222584
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is there a place for epoetin alfa in managing anemia during critical illness?
    Givens M; Lapointe M
    Clin Ther; 2004 Jun; 26(6):819-29. PubMed ID: 15262453
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anemia and response to epoetin alfa: the cause of anemia matters!
    Dharmarajan TS
    J Am Geriatr Soc; 2008 Aug; 56(8):1574-5. PubMed ID: 18808607
    [No Abstract]   [Full Text] [Related]  

  • 31. New oversight put in place for physicians giving anemia drugs to patients with cancer.
    Mitka M
    JAMA; 2010 Apr; 303(14):1355-6. PubMed ID: 20388885
    [No Abstract]   [Full Text] [Related]  

  • 32. Questionable conclusions about epoetin alfa.
    Kruse MW; Lee JJ
    Am J Health Syst Pharm; 2007 Sep; 64(17):1789-90; author reply 1790-1. PubMed ID: 17724355
    [No Abstract]   [Full Text] [Related]  

  • 33. Resource utilisation and time commitment associated with correction of anaemia in cancer patients using epoetin alfa.
    Lynch DM; Slaven T
    Clin Drug Investig; 2007; 27(9):661-2. PubMed ID: 17705574
    [No Abstract]   [Full Text] [Related]  

  • 34. Case history. 2: The use of epoetin alfa before high-dose chemotherapy.
    Mertelsmann R
    Ann Oncol; 1997; 8 Suppl 3():S13. PubMed ID: 9341961
    [No Abstract]   [Full Text] [Related]  

  • 35. Erythropoietic agents in peritoneal dialysis.
    Muirhead N
    Perit Dial Int; 2005; 25(6):547-50. PubMed ID: 16411519
    [No Abstract]   [Full Text] [Related]  

  • 36. Erythropoietin, the biology of erythropoiesis and epoetin alfa. An overview.
    Bieber E
    J Reprod Med; 2001 May; 46(5 Suppl):521-30. PubMed ID: 11396386
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of epoetin alfa in chemotherapy patients: a consistent profile of efficacy and safety.
    Itri LM
    Semin Oncol; 2002 Jun; 29(3 Suppl 8):81-7. PubMed ID: 12082659
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of Epoetin alfa on quality of life in anemic cancer patients.
    Cella D; Bron D
    Cancer Pract; 1999; 7(4):177-82. PubMed ID: 10687582
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overview of cancer-related anemia: focus on the potential role of darbepoetin alfa.
    Valley AW
    Pharmacotherapy; 2002 Sep; 22(9 Pt 2):150S-159S. PubMed ID: 12222585
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of three kinds of erythropoiesis-stimulating agents on renal anemia in Japanese non-dialysis chronic kidney disease patients.
    Kuwahara M; Hasumi S; Mandai S; Tanaka T; Shikuma S; Akita W; Mori Y; Sasaki S
    Clin Exp Nephrol; 2014 Oct; 18(5):755-62. PubMed ID: 24317507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.